Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei
arznei-telegramm® 02/2018

SPOT ON
Pre-exposure prophylaxis for HIV infection with tenofovir/emtricitabine (TRUVADA, generics) efficacious, recommended, but not reimbursed?

NEW ON THE MARKET
Naltrexone/bupropion (MYSIMBA): controversial fixed-dose combination for the treatment of obesity

CURRENT ADR NETWORK REPORT
Impulse control disorders with combinations of aripiprazole (ABILIFY, generics) with other neuroleptics  free article 
Once again: anaphylaxis with sublingual immunotherapy (GRAZAX, ORALAIR)

SIDE EFFECTS
Liver damage with IBEROGAST: warning overdue by years
New anticoagulants and gout
Fungaemia: new contraindication for saccharomyces boulardii containing products (e.g. PERENTEROL)
Restrictions of use for ulipristal acetate (ESMYA) against uterine fibroids
Liver damage: marketing withdrawal of flupirtine (KATADOLON, generics) in sight

e a-t ON THE INTERNET
On the benefit of IBEROGAST
© 2018 arznei-telegramm